FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16665711000001104: Rotigotine 3mg/24hours transdermal patches (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Mar 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
58567601000001113 Rotigotine 3mg/24hours transdermal patches (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58567701000001115 Rotigotine 3mg/24hours transdermal patches en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rotigotine 3mg/24hours transdermal patches Is a Rotigotine true Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route patch.transdermal ontology form and route true Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Transdermal route true Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Plays role Antiparkinson therapeutic role true Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Is a Product containing rotigotine false Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has active ingredient Rotigotine false Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has specific active ingredient Rotigotine true Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has manufactured dose form Prolonged-release transdermal patch false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Neupro 3mg/24hours transdermal patches (UCB Pharma Ltd) Is a True Rotigotine 3mg/24hours transdermal patches Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches 28 patch Has VMP True Rotigotine 3mg/24hours transdermal patches Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start